Clinical trial
Safety, Biodistribution and Radiation Dosimetry of [18F]PARPi
NCT03631017 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety, Biodistribution and Radiation Dosimetry of [18F]PARPi
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- August 10, 2018
- Completion date
- August 31, 2027
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer